Early treatment could prove beneficial for patients with high-risk smouldering myeloma
Smouldering myeloma patients are generally not treated until symptoms develop. The current standard of care is observation. Previous attempts at treating smouldering myeloma with older treatments such as alkylating agents either were not effective or led to concerns about long-term toxicity.